Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN4 | O15554 | 4/20 | 0.48 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.44 |
| ▸ | KIF11 | P52732 | 4/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL10687152 | 0.98 | KCNN4 (0.46) | KCNN4TAAR1KIF11SLC6A2CYP1A2 | |
| SCHEMBL10384482 | 0.86 | KIF11 (0.45) | KCNN4TAAR1KIF11ESR1ESR2 | |
| SCHEMBL6249559 | 0.84 | PTPN1 (0.41) | KCNN4KIF11 | |
| SCHEMBL3402192 | 0.84 | KCNN4 (0.42) | KCNN4TAAR1KIF11 | |
| SCHEMBL9756593 | 0.83 | KCNN4 (0.46) | KCNN4TAAR1KIF11SLC6A2CYP1A2 | |
| SCHEMBL453502 | 0.83 | KCNN4 (0.46) | KCNN4TAAR1KIF11SLC6A2CYP1A2 | |
| SCHEMBL10589325 | 0.82 | SCN5A (0.42) | KCNN4KIF11 | |
| SCHEMBL11757213 | 0.82 | SCN5A (0.42) | KCNN4KIF11 | |
| SCHEMBL11751250 | 0.82 | SCN5A (0.42) | KCNN4KIF11 | |
| SCHEMBL2836376 | 0.82 | SCN5A (0.42) | KCNN4KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 556 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007062862-A2 | USE OF CALMODULIN INHIBITORS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS | LUDWIG MAXIMILIANS UNIVERSITÄT MÜNCHEN (DE) | 2007-06-07 | — | — | WO | claimed |
| US-20030064929-A1 | Modulating body/cranial hair growth | DURANTON ALBERT (FR) | 2003-04-03 | — | — | US | claimed |
| EP-0648488-B1 | Method to alter hairgrowth and compositions therefor | OREAL (FR) | 2000-11-29 | — | — | EP | claimed |
| US-5928654-A | Modulating body/cranial hair growth with lipoxygenase/cyclooxygenase inhibitors | SOCIETE L'OREAL S.A. (FR) | 1999-07-27 | — | — | US | claimed |
| EP-0800815-A2 | Use of at least one lypoxygenase inhibitor and at least one cyclo-oxygenase inhibitor to alter hair growth | L'OREAL (FR) | 1997-10-15 | — | — | EP | claimed |
| EP-0648488-A1 | Method to alter hairgrowth and compositions therefor | L'OREAL (FR) | 1995-04-19 | — | — | EP | claimed |
| EP-0428754-B1 | HAIR GROWTH STIMULANT | SHISEIDO CO LTD (JP) | 1994-05-25 | — | — | EP | claimed |
| EP-0428754-A1 | HAIR GROWTH STIMULANT | SHISEIDO COMPANY LIMITED (JP) | 1991-05-29 | — | — | EP | claimed |
| EP-0168626-B1 | COMPOSITION FOR THE MANUFACTURE OF A MEDICAMENT FOR THE THERAPEUTIC TREATMENT OF TRAUMA OF THE SKIN | BAR-ILAN UNIVERSITY (IL) | 1990-09-12 | — | — | EP | claimed |
| US-4654323-A | BLOCKING AGENT FOR CALCIUM CALMODULIN COMPLEX | BAR ILAN UNIVERSITY (IL) | 1987-03-31 | — | — | US | claimed |
| EP-0168626-A1 | Composition for the manufacture of a medicament for the therapeutic treatment of trauma of the skin | BAR-ILAN UNIVERSITY (IL) | 1986-01-22 | — | — | EP | claimed |
| EP-0082203-A1 | USE OF CALMODULIN BINDING DRUGS IN UTERUS TO PREVENT PREGNANCY | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1983-06-29 | — | — | EP | claimed |
| US-4377577-A | Use of psychoactive drugs in uterus to prevent pregnancy | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1983-03-22 | — | — | US | claimed |
| WO-1983000086-A1 | USE OF CALMODULIN BINDING DRUGS IN UTERUS TO PREVENT PREGNANCY | UNIV GEORGIA RES FOUND (US) | 1983-01-20 | — | — | WO | claimed |
| EP-0053108-A1 | VAGINAL CONTRACEPTIVES COMPRISING PSYCHOACTIVE DRUGS | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1982-06-09 | — | — | EP | claimed |
| WO-1981003421-A1 | USE OF PSYCHOACTIVE DRUGS AS VAGINAL CONTRACEPTIVES | UNIV GEORGIA (US) | 1981-12-10 | — | — | WO | claimed |
| JP-54084578-A | — | — | None | — | — | JP | disclosed |
| CN-119365447-A | Process for preparing substantially nitrosamine-free, peroxide-free, substantially colorless amine oxide | 巴斯夫欧洲公司 | 2025-01-24 | — | — | CN | disclosed |
| JP-S5484578-A | NOVEL PREPARATION OF DIPHENYLBUTYLAMINE DERIVATIVE | SUMITOMO CHEM CO LTD | 1979-07-05 | — | — | JP | disclosed |
| US-4034011-A | 1,1-Diphenyl-4-(substituted-amino)butanes | ELI LILLY AND COMPANY (US) | 1977-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030064929-A1 | Modulating body/cranial hair growth | ALOX15B, ALOX12, ALOX5 | KCNN4 3541/4885TAAR1 1922/4885KIF11 4542/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.